122 results
Page 2 of 7
8-K
EX-99.2
q9nnuxk1z
18 Jul 22
Invitae Announces Strategic Business Realignment to Accelerate Its Path to Positive Cash Flow
9:28pm
PRE 14A
erqjz6pc2
4 Apr 22
Preliminary proxy
4:15pm
424B5
bo97d3e
2 Mar 22
Prospectus supplement for primary offering
8:24am
S-3ASR
hpesqhuhfqn5kul7
2 Mar 22
Automatic shelf registration
6:06am
8-K
EX-99.2
97aa6dcz
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
8-K
EX-99.1
8u87l1xnk2d2
7 Sep 21
Invitae to Acquire Ciitizen to Strengthen its Patient-Consented Health Data Platform to Improve Personal Outcomes and Global Research
8:01am
8-K
EX-1.1
cz17qf
4 May 21
Entry into a Material Definitive Agreement
5:15pm
8-K
EX-10.1
nwxnw4gnud41
5 Apr 21
Invitae Announces $1.15 Billion Investment Supporting Ongoing Growth Initiatives
4:13pm
8-K/A
EX-99.4
z5u3dh1 cev6
5 Apr 21
Financial Statements and Exhibits
4:11pm
8-K
EX-99.1
umphws17imff1go
17 Feb 21
Invitae Reports $279.6 Million in Annual Revenue Driven by 659,000 in Billable Volume in 2020
4:09pm
8-K
EX-1.1
3cyuph
26 Jan 21
Invitae Announces Pricing of Public Offering of Common Stock
4:12pm
424B5
89yokef
25 Jan 21
Prospectus supplement for primary offering
4:02pm
424B5
vzuawr
20 Jan 21
Prospectus supplement for primary offering
4:24pm